Comparison of two currently available anti-COVID-19 vaccines

IF 0.2 Q4 ALLERGY

Alergologia Polska - Polish Journal of Allergology Pub Date : 2021-01-01 DOI:10.5114/PJA.2021.102554

R. Pawliczak

引用次数: 2

Abstract

At the end of 2020, the all-over-the-world vaccination against COVID-19 programs have been launched Currently in Poland we have two vaccines available In this short review we are trying to compare them, based on available literature data This may help physicians and patients All parties should have in mind that this data are limited by time and number of exposed, so it will be changing while the vaccinated population is growing

查看原文本刊更多论文

目前两种抗covid -19疫苗的比较

在2020年底，针对COVID-19的全球疫苗接种计划已经启动。目前在波兰，我们有两种疫苗可用。在这篇简短的综述中，我们试图根据现有的文献数据对它们进行比较。这可能有助于医生和患者。所有各方都应该记住，这些数据受时间和暴露数量的限制，因此随着接种疫苗的人口的增长，它会发生变化

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Alergologia Polska - Polish Journal of Allergology ALLERGY-

自引率

50.00%

发文量

期刊介绍： Alergologia Polska - Polish Journal of Allergology is aimed mainly at allergologists, but also medical doctors working in related fields, such as otolaryngology, pulmonology, and dermatology. The main goal of the journal is to ensure rapid publication of important research papers and interesting case studies from the following areas: allergology, diagnostics, therapy of allergic diseases, in particular in the area of immunotherapy, rhinitis, asthma. The Editorial Board accepts for publication original papers, case studies and letters to the Editor. We also publish review articles (both commissioned and those agreed upon with the Editor-in-Chief), articles dealing with standards of medical practice, as well as special issues. The journal is published quarterly. We guarantee short review times (up to two weeks) and immediate publication on-line upon Editor acceptance.